- An innovative pharma company with a 150-year history
- €1.70B net profit in 2018
- Sales increased by 4.10% in Q1 2019
- EBITDA rose by 44.60%
Barclays Capital |
Hold |
50 EUR
|
08.12.2020 |
Bernstein Research |
Buy |
74 EUR
|
01.12.2020 |
Goldman Sachs Group Inc. |
Buy |
73 EUR
|
12.11.2020 |
Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
Buy |
60 EUR
|
05.11.2020 |
Buy
Based on the analytics from 30 of the world's largest investment banks over the past 3 months
Target price
49.69 EUR(-2.59% Growth potential)
Based on the data from 30 of the leading investment banks
Receive ideas for profitable investments - faster than the market
We will be sending you a letter once a week with the most relevant information
Congratulations!
Now you will always be aware of which stocks are more profitable to invest in